---
title: "Eating attitudes and glycaemic control in adolescents with Type 1 DM: a cross-sectional analysis"
id: "plos-one-21-eating-behaviour-and-glycaemic-control-a-cross-sectional-study-in-adolescents"
canonical_url: "https://medichelpline.com/clinical-feed/plos-one-21-eating-behaviour-and-glycaemic-control-a-cross-sectional-study-in-adolescents"
content_type: "clinical_feed_article"
specialty: "Pediatrics"
source_name: "PLOS ONE (Medicine)"
source_url: "https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361574"
published_at: "2026-10-29T14:00:00.000Z"
evidence_level: "Journal Feed"
license: "CC-BY-NC-4.0 / Informational Use"
---
# Eating attitudes and glycaemic control in adolescents with Type 1 DM: a cross-sectional analysis
## Provenance & Clinical Metadata
- **Canonical URL:** https://medichelpline.com/clinical-feed/plos-one-21-eating-behaviour-and-glycaemic-control-a-cross-sectional-study-in-adolescents
- **Specialty:** [Pediatrics](https://medichelpline.com/clinical-feed/pediatrics.md)
- **Primary Source:** PLOS ONE (Medicine)
- **Source URL:** [Original Journal Publication](https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0361574)
- **Published At:** 2026-10-29T14:00:00.000Z
- **Evidence Rating:** Journal Feed
## Executive GIST (TL;DR)
- This cross-sectional study enrolled 143 adolescents with diabetes aged 10–19 years who attended a pediatric endocrinology clinic between February and April 2024. - Investigators collected demographic and disease data, measured **HbA1c** and **BMI**, and administered the **EAT-26** (Eating Attitudes Test) by face-to-face questionnaire. - The cohort mean age was 14 ± 2.3 years; 56.6% were female and 49.7% had diabetes duration between 1–5 years. - Mean EAT-26 total score for the sample was 16.62 ± 8.30, below the common screening cutoff of 20 points. - Subscale means were: Dieting 10.39 ± 5.58; Bulimia/food preoccupation 2.33 ± 3.03; Oral Control 3.79 ± 3.08. - Investigators found no significant association between EAT-26 total score and glycaemic control (HbA1c classified by ISPAD thresholds). - Differences in total and subscale EAT-26 scores were observed across selected demographic and clinical characteristics, including **BMI**, treatment modality, and reported treatment adherence. - Internal consistency (Cronbach’s α) for the full EAT-26 was 0.688; subscale α varied (Diet 0.662; Bulimia 0.534; Oral Control 0.549), which the authors reported as acceptable for total score but lower for some subscales. - Statistical methods: nonparametric tests (Kruskal–Wallis, Dunn–Bonferroni), Spearman correlation, and multivariable linear regression with **HbA1c** as the dependent variable; significance set at p<0.05. - Limitations documented by the authors include cross-sectional design, nonpublic dataset (consent restrictions), and variable subscale reliability; these restrict causal inference and secondary data sharing.
## Clinical Analysis & Structured Key Points
Eating behaviour and glycaemic control: A cross-sectional study in adolescents with diabetes | PLOS One Browse Subject Areas ? Click through the PLOS taxonomy to find articles in your field. For more information about PLOS Subject Areas, click here . Article Authors Metrics Comments Media Coverage Reader Comments Figures Figures Abstract Background Achieving early glycemic control in adolescents with diabetes is associated with improved short- and long-term health outcomes. The aim of this study was to examine the relationship between eating attitudes and glycemic control, as well as the factors associated with eating attitudes and glycemic control, in adolescents with diabetes. Methods This descriptive cross-sectional study included 143 adolescents with diabetes, aged 10–19 years, who attended a research hospital between February and April 2024. The data were collected using a Descriptive Information Form, Eating Attitudes Test (EAT) and an information form questioning the values of some metabolic variables. Results The mean age of the participants was 14 ± 2.3 years and 49.7% had diabetes between 1–5 years. The mean total score of the EAT scale was 16.62 ± 8.30. The mean score of the “Dieting” subscale of the EAT scale was 10.39 ± 5.58, the mean score of the “Bulimia food preoccupation” subscale was 2.33 ± 3.03 and the mean score of the “Oral Control” subscale was 3.79 ± 3.08. There was no significant difference between the mean EAT total score and glycemic control. Conclusions The mean EAT-26 total score was below the commonly used cutoff score, and no significant association was found between EAT-26 scores and HbA1c. Differences in EAT-26 total and subscale scores were observed according to selected demographic and clinical characteristics, including BMI, treatment modality, and treatment adherence. These findings describe self-reported eating attitudes in the study sample and support the inclusion of eating-related assessment within the holistic care of adolescents with Type 1 DM. Citation: Şimşekoğlu N, Arslanoğlu İ, Portakal B, Aktaş S (2026) Eating behaviour and glycaemic control: A cross-sectional study in adolescents with diabetes. PLoS One 21(10): e0361574. https://doi.org/10.1371/journal.pone.0361574 Editor: Omnia S. El Seifi, University of Tabuk, SAUDI ARABIA Received: May 13, 2026; Accepted: October 13, 2026; Published: October 29, 2026 Copyright: © 2026 Şimşekoğlu et al. This is an open access article distributed under the terms of the Creative Commons Attribution License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Data Availability: The data underlying the findings of this study are not publicly available because the informed consent obtained from participants and their legal guardians did not include permission for public data sharing, and the dataset contains potentially identifiable sensitive health information. Data may be made available to qualified researchers upon reasonable request and subject to approval by the University of Health Sciences Turkey Hamidiye Scientific Research Ethics Committee and applicable ethical and data protection regulations. Hamidiye Scientific Research Ethics Committee Secretariat, University of Health Sciences, Mekteb-i Tıbbiye-i Şahane (Hamidiye) Campus, Selimiye Mah., Tıbbiye Dist. No: 38, 34668 Üsküdar, İstanbul, Türkiye, Extension: 2631 hamidiye.baek@sbu.edu.tr . Funding: The author(s) received no specific funding for this work. Competing interests: The authors have declared that no competing interests exist. Abbreviations: EAT, Eating Attitudes Test; BMI, Body mass index; Type 1 DM, Type 1 Diabetes; IDF, International Diabetes Federation; HbA1c, Glycated hemoglobin; β cells, Beta cells; ISPAD, International Society for Pediatric and Adolescent Diabetes; WHO, World Health Organization; ED, Eating disorders; EDNOS, Eating Disorders Not Otherwise Specified; AN, Anorexia Nervosa; BN, Bulimia Nervosa; DKA, Diabetic ketoacidosis; EAT-40, The Eating Attitudes Test-40; EAT-26, Eating Attitudes Test-26; MS, Multiple sclerosis; DBM, Doubly burdened malnutrition; MDMA, Methylenedioxymethamphetamine Introduction Diabetes mellitus (DM) is a common condition that is associated with increasing mortality and morbidity. Type 1 DM is an autoimmune disease characterised by insulin secretion deficiency associated with the destruction of β cells and associated hyperglycemia [ 1 , 2 ]. In the 2022 report of the International Diabetes Federation (IDF), it was reported that there are approximately 8.4 million individuals diagnosed with Type 1 DM worldwide and 1.5 million (18%) of them are under the age of 20. It has been reported that the incidence of Type 1 DM, which is childhood diabetes, is increasing by an average of 3–4% per year [ 3 , 4 ]. The management of Type 1 DM is a complex process that aims to prevent the emergence of acute and chronic complications while maintaining glycemic control [ 5 , 6 ]. Ensuring optimal glycemic control in this process is important for improving short- and long-term health outcomes [ 7 , 8 ]. HbA1c value is an important marker for the evaluation of glycemic control level of individuals [ 1 ]. The International Society for Pediatric and Adolescent Diabetes (ISPAD) recommends an HbA1c value below 7.5% (58 mmol/L) as a glycemic control target [ 4 , 9 , 10 ]. The earlier the HbA1c level is controlled, the greater the favourable effect [ 9 ]. As a matter of fact, the Epidemiology of Diabetes Interventions and Complications (EDIC) study, by drawing attention to the concept of metabolic memory, stated that high blood glucose levels in the early years of Type 1 DM will be effective in the development of long-term complications and emphasised the importance of early insulin treatment in preventing these complications. Early and intensive control of diabetes provides protection against macrovascular and microvascular complications and supports the expected growth and development in adolescence. It will also contribute to the reduction of the economic and care burden of the health system and caregivers [ 4 , 7 ]. Despite promising therapeutic advances, such as improved diabetes technology and new adjuvant medications, and improved quality of health care delivery, only 21% of adolescents achieve target glycemic control [ 4 , 8 , 9 ]. Individuals with Type 1 DM have to deal with many problems in their daily lives to maintain glycemic control. Achieving glycemic control requires adherence to a strict regime including regular attendance at scheduled appointments, carbohydrate calculations, multiple insulin administration, frequent blood glucose measurements, continuous diet planning and exercise programmes [ 11 , 12 ]. However, these demanding self-management tasks may be associated with reduced independence, lower treatment adherence, and greater challenges in diabetes management. These challenges may become even more pronounced during adolescence, a transitional period between childhood and adulthood [ 5 , 12 , 13 ]. Adolescence, defined by WHO as the period between the ages of 10–19, is a life stage characterized by significant changes in biological, psychological and social dimensions. Factors such as limited problem-solving skills, adolescent rebellion, peer pressure, the transition of diabetes management responsibility from parents to adolescents, and dietary habits may be associated with poorer adherence to diabetes management among adolescents [ 8 , 14 ]. Attitudes and habits related to nutrition established during this period are considered important determinants of adolescent health in both the short and long term [ 15 ]. Due to the intense emotional fluctuations seen in adolescence and the physiological burden of Type 1 DM, this period is considered a critical period for the development of eating disorders [ 16 ]. A significant cause of difficulty in glycemic control during childhood and adolescence is eating disorders (ED). ‘Eating disorders (ED)’ is a catch-all term for pathological behaviors related to eating. Eating disorders are categorised as Eating Disorders Not Otherwise Specified (EDNOS), which includes specific eating disorders such as Anorexia Nervosa (AN) and Bulimia Nervosa (BN) and all other types of eating disorders [ 1 , 17 ]. Eating disorders in diabetic individuals were first observed in the 1970s. Eating disorders are reported in approximately 20% of women with DM and are approximately twice as common among adolescent girls with Type 1 DM than among their peers without diabetes [ 18 – 20 ]. High BMI in adolescence, body image concerns, presence of conflict in the family, deterioration in mother-daughter relationship, low self-esteem, longer duration of diabetes and poor metabolic control, avoidant and negative coping methods related to the disease increase the risk of eating disorders in diabetic individuals. In addition, the fact that they have to pay attention to meal times, the content of the foods consumed and the amount of energy and carbohydrate in a portion for the regulation of insulin treatments during the diabetes treatment process increases the risk of developing eating disorders in adolescents [ 6 , 20 ]. In the Transdiagnostic Care Model developed by Fairburn (2003), it was reported that characteristics such as low self-esteem and perfectionism trigger eating disorders in Type 1 diabetic individuals [ 12 , 21 ]. Since symptoms of disordered eating including behaviors such as overeating, binge eating, use of laxatives or diuretics, excessive exercise and self-induced vomiting in individuals with Type 1 DM may develop into significant eating disorders over time, it is important to identify these concerns early period and to prepare treatment and care protocols [ 1 , 20 , 22 ]. Diabulimia, which is described as “The World’s Most Dangerous Eating Disorder”, is characterised by deliberate restriction of insulin that causes weight gain in diabetic individuals [ 1 , 23 ]. Although previous studies have investigated the relationship between disordered eating behaviors and glycemic outcomes in adolescents with Type 1 DM, the available evidence remains limited and inconsistent due to differences in study populations, assessment methods, and sociocultural contexts. Furthermore, most existing studies have primarily focused on clinically diagnosed eating disorders or diabetes-specific eating problems, whereas evidence regarding general eating attitudes and their relationship with glycemic control is still limited, particularly among adolescents from different cultural settings. Therefore, further evidence is needed to clarify this relationship and to better understand the potential role of eating attitudes in diabetes management among adolescents with Type 1 DM [ 16 , 24 ]. By examining the association between eating attitudes and glycemic control in adolescents with Type 1 DM, this study aims to address an important gap in the literature and provide evidence from a Turkish population, where data on this topic remain scarce. The findings are expected to contribute to a better understanding of behavioral factors associated with glycemic control and to inform future research and the development of targeted interventions for improving diabetes management in adolescents. Accordingly, the aim of this study was to examine the relationship between eating attitudes and glycemic control among adolescents with Type 1 DM. Research questions Is there a relationship between disordered eating attitudes and glycemic control variables in adolescents with diabetes? Are disordered eating attitudes in adolescents with diabetes associated with demographic and disease-related variables? Methods Study design This study was designed as a descriptive cross-sectional study. The STROBE checklist for cross-sectional studies was used in reporting this study. Place and time of the study The study was conducted in the Pediatric Endocrinology Outpatient Clinic of a research hospital between 10/02/2024–26/04/2024. Sample The population of the study consisted of adolescents with diabetes who applied to the Pediatric Endocrinology Outpatient Clinic of a research hospital. Adequate sample size for the study was calculated with the ‘ pwrss ’ package of RStudio ( version 9.3, Armonk, NY:IBM Corp ) programme. In the literature review [ 25 ], based on the percentage measurement values of the methods to be studied; in the pearson correlation test (double tail); The sample size was calculated as 121 when the error level ( α )=0.05, the power of the test ( 1-β )=0.80 and r 1 (minimum correlation coefficient)=0.35 were taken. The study was completed with 143 adolescents with diabetes who agreed to be included in the study. All participants who met the inclusion criteria and agreed to participate in the study were included using a sequential sampling method. Of the 168 participants invited to the study, 143 participated, resulting in a response rate of 85%. There were no missing data in the dataset that would affect the analyses. Forms with missing or incorrectly filled-in information were excluded from the analysis. Due to the cross-sectional study design, there were no cases of loss to follow-up or participants who withdrew from the study during the data collection process. Inclusion criteria: -. Adolescents aged 10–19 years, -. 18 and 19 years old and approved the informed consent form, -. Under 18 years old and approved the informed consent form by their parents, -. Diagnosed with Type 1 DM at least 6 months ago, -. Without visual and hearing impairment, -. Literate, -. Examined in the Pediatric Endocrinology Outpatient Clinic of a research hospital between 10/02/2024-26/04/2024 were included in the study. Data collection Descriptive Information Form, Eating Attitudes Test and information form questioning the values of some metabolic variables were used as data collection tools. The data were collected by the researchers by applying a face-to-face questionnaire to the patients in approximately 5–6 minutes. Descriptive information form The “Descriptive Information Form,” consisting of a total of 28 questions, aims to examine the demographic characteristics of the participants with the first 9 questions, and the following 19 questions with disease-related characteristics. Eating attitudes test-26 (EAT-26) The Eating Attitudes Test-40 (EAT-40) was developed by Garner and Garfinkel (1979) to determine anorectic/bulimic attitudes and behaviors. EAT-40 was later revised by Garner et al. (1982) and a short form with 26 questions was developed. In a pilot study conducted by Devran (2014) using the translated form of EAT-26, Cronbach’s α coefficient was 0.70 and the intraclass correlation coefficient was 0.95. Eating attitudes test-26 consists of 26 items. The items of the scale were prepared in the form of a six-point Likert scale. The items consist of ‘always’, ‘usually’, ‘frequently’, ‘sometimes’, “rarely” and ‘never’ options. Questions 1–25 are evaluated as always = 3; usually = 2; frequently = 1; other options = 0 points. Question 26 is scored in the opposite direction (never = 3, rarely = 2, sometimes = 1, other options = 0). A total score is obtained by scoring all questions. The total score ranges from 0 to 78 and ≥ 20 points is considered as cutoff value. A total score of 20 or above is commonly used as a positive screening threshold indicating the need for further assessment; it does not establish a clinical diagnosis [ 25 ]. The EAT-26 consists of three subscales: dieting behavior (1.,6.,7.,10.,11.,12.,14.,16.,17.,22.,23.,24.,26. items), Bulimia and food preoccupation (3.,4.,9.,18.,21.,25.items) and oral control (2.,5.,8.,13.,15.,19.,20. items), allowing more information to be obtained from a single scale. Dieting behavior is highly correlated with an impaired body image. Bulimic behavior is closely related to body weight and provides information about the tendency to bulimic behavior and body perception. Oral control behavior reflects a tendency for self-control. High scores in this domain are associated with the absence of bulimia, and low body weight. Among the subscales of the scale, dieting score is calculated by summing the scores of 13 questions, bulimic behavior score is calculated by summing the scores of 6 questions and oral control behavior score is calculated by summing the scores of 7 questions. The cutoff values for dieting, Bulimia and food preoccupation and oral control subscales are 18, 4 and 5 points, respectively [ 25 ]. As a result of the reliability analysis regarding the internal consistency of the Eating Attitudes Test (EAT) scale, the total Cronbach’s α coefficient of the scale was calculated as 0.688. When evaluated according to the subscales, the Cronbach’s α coefficient of the ‘Diet’ subscale was 0.662, the “Bulimia food preoccupation” subscale was 0.534 and the ‘Oral Control’ subscale was 0.549. These results show that especially the total scale and the ‘Diet’ subscale have an acceptable level of internal consistency. Glycemic control variables information form This form was used to assess metabolic control variables, including HbA1c and BMI values. HbA1c values were obtained from laboratory records during the same clinical visit as the questionnaire administration and were not based on participant self-report. Glycemic control was classified according to HbA1c levels as good (<7.5%) or poor (≥7.5%), in accordance with the International Society for Pediatric and Adolescent Diabetes (ISPAD) guidelines. Analysis of data Statistical analyses in this study were performed using SPSS 25.0 (Released 2017. IBM SPSS Statistics for Windows, Version 25.0. Armonk, NY: IBM Corp) and visualization was performed using RStudio version 2024.12.1 + 563 ‘Kousa Dogwood’ (Windows 10 based system) and Quarto 1.5.57 platform. The distribution characteristics of the data were evaluated with descriptive statistics, and the normality assumption was checked. Since the variables did not show normal distribution, nonparametric methods were preferred in the analyses. The differences of EAT total score and subscale scores (Diet, Bulimia food preoccupation and Oral Control) according to demographic and disease-related variables were analyzed by Kruskal-Wallis H test. In cases where a significant difference was found as a result of the Kruskal-Wallis test, within-group pairwise comparisons were made with the Dunn-Bonferroni post hoc test. In addition, Spearman’s rank-order correlation difference correlation analysis was used to examine the relationships between EAT and its subscale scores and continuous variables (age, HbA1c level and BMI). To evaluate whether eating attitudes were independently associated with glycaemic control, a multivariable linear regression analysis was performed with HbA1c as the dependent variable and EAT-26 total score, age, gender, BMI z-score, diabetes duration, dietary adherence, physical activity, and meal skipping as independent variables. Statistical significance level was accepted as p < 0.05. Ethics statement The ethics committee of the University of Health Sciences approved the current study (Decision No: 23–705), which was conducted in accordance with the ethical code of the Declaration of Helsinki. In the light of the principle of voluntariness, written informed consent was obtained from all participants aged 18 years or older. For participants under 18 years of age, written informed consent was obtained from their parents or legal guardians, and written assent was obtained from the adolescents prior to their participation in the study. Results The findings related to the socio-demographic and disease characteristics of the individuals included in the study are given in Table 1 . Accordingly, it was found that the mean age of the participants included in the study was 14 ± 2.3, 81(56.6%) were female, 5(3.5%) were married, 71(49.7%) were prima
## Related Clinical Research

- [High blood pressure in Ugandan children and adolescents with Type 1 diabetes: multicenter prevalen](https://medichelpline.com/clinical-feed/plos-one-11-high-blood-pressure-among-children-and-adolescents-with-type-1-diabetes.md)
- [Childhood type 1 diabetes incidence fell after Finland’s COVID-19 lockdown peak](https://medichelpline.com/clinical-feed/plos-medicine-0-trends-in-the-incidence-of-childhood-type-1-diabetes-after-the-covid-19.md)
- [Self-monitoring frequency linked to glycaemic control in Kenyan children with Type 1 diabetes](https://medichelpline.com/clinical-feed/medrxiv-10-factors-associated-with-poor-glycaemic-control-among-children-and-adolescents.md)
- [Type 1 Diabetes Care: Hypoglycemia Burden and Beta-Cell Replacement Research](https://medichelpline.com/clinical-feed/endocrine-news-0-type-1-diabetes-setting-the-scene-and-the-evolution-of-type-1-diabetes-care.md)
- [U.S. POINTER: Structured lifestyle program slows brain aging and cardiometabolic risk over 24 mont](https://medichelpline.com/clinical-feed/medical-news-today-0-combining-physical-mental-and-social-habits-slows-brain-aging-in-2-year-trial.md)

## Navigation
- [← Back to Pediatrics Feed](https://medichelpline.com/clinical-feed/pediatrics.md)
- [← All Clinical Specialties](https://medichelpline.com/clinical-feed.md)
## Medical & Regulatory Disclaimer

> [!CAUTION]
> MedicHelpline content is structured for research, educational, and professional discovery purposes. It does not constitute individual medical advice, clinical diagnosis, or treatment recommendations.
> Always verify dosing, contraindications, and regulatory alerts against official product labeling and primary regulatory sources before clinical decision-making.